Silence Therapeutics SLN
NASDAQ SLN
$10.80 -0.40 (-3.57%)
At close: Sep 29, 2026 · 4:00 PM EDT

Silence Therapeutics (SLN) Operating Leases (2023 - 2026)

Updated

Silence Therapeutics (SLN) posted Operating Leases of $9,000 for the quarter ended Jun 30, 2026, down 79.1% from the prior quarter.

Analysis

Silence Therapeutics (SLN) Operating Leases (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Silence Therapeutics' Operating Leases came in at $71,000.

  • In prior years, Silence Therapeutics' Operating Leases was $118,000 in the year ended Dec 31, 2023.
  • According to Business Quant data, Operating Leases for the three prior quarters was $43,000 (quarter ended Mar 31, 2026), $71,000 (quarter ended Dec 31, 2025) and $97,000 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Silence Therapeutics 529.16 Mn 457.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Mar 31, 2026 43,000.00
Dec 31, 2025 71,000.00
Sep 30, 2025 97,000.00
Dec 31, 2023 115,427.13
API Access

Silence Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SLN&period=max&api_key=YOUR_API_KEY